Holen Sie sich die Stockscreener-App
3.29
7.58%
-0.27
Handel nachbörslich:
3.29
Schlusskurs vom Vortag:
$3.56
Offen:
$3.49
24-Stunden-Volumen:
1.66M
Relative Volume:
0.46
Marktkapitalisierung:
$355.00M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-258.08M
KGV:
-1.1964
EPS:
-2.75
Netto-Cashflow:
$-202.32M
1W Leistung:
-17.13%
1M Leistung:
+4.44%
6M Leistung:
-58.93%
1J Leistung:
-80.44%
1-Tages-Spanne:
$3.28
$3.53
1-Wochen-Bereich:
$3.28
$3.95
52-Wochen-Spanne:
$2.19
$18.17
Rocket Pharmaceuticals Inc Stock (RCKT) Company Profile
Firmenname
Rocket Pharmaceuticals Inc
Sektor
Branche
Telefon
646-440-9100
Adresse
350 FIFTH AVENUE, NEW YORK, NY
Vergleichen Sie RCKT mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
RCKT
Rocket Pharmaceuticals Inc
|
3.29 | 384.14M | 0 | -258.08M | -202.32M | -2.75 |
|
VRTX
Vertex Pharmaceuticals Inc
|
421.67 | 109.22B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
628.00 | 67.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
423.47 | 57.35B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
831.48 | 50.87B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
182.77 | 39.72B | 447.02M | -1.18B | -868.57M | -6.1812 |
Rocket Pharmaceuticals Inc Stock (RCKT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-08-20 | Hochstufung | BofA Securities | Neutral → Buy |
| 2025-07-25 | Herabstufung | BofA Securities | Buy → Neutral |
| 2025-05-30 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2025-05-28 | Herabstufung | Goldman | Neutral → Sell |
| 2025-05-28 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2025-05-28 | Herabstufung | Jefferies | Buy → Hold |
| 2025-05-28 | Herabstufung | Leerink Partners | Outperform → Market Perform |
| 2025-05-28 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2025-05-27 | Herabstufung | Needham | Buy → Hold |
| 2025-05-27 | Herabstufung | TD Cowen | Buy → Hold |
| 2025-03-12 | Eingeleitet | BMO Capital Markets | Outperform |
| 2024-12-30 | Eingeleitet | Wedbush | Outperform |
| 2024-12-18 | Eingeleitet | Jefferies | Buy |
| 2024-10-16 | Eingeleitet | Scotiabank | Sector Outperform |
| 2024-04-02 | Eingeleitet | Goldman | Neutral |
| 2023-10-24 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2023-02-01 | Eingeleitet | Morgan Stanley | Overweight |
| 2022-11-08 | Eingeleitet | Canaccord Genuity | Buy |
| 2022-11-01 | Eingeleitet | BTIG Research | Buy |
| 2022-07-08 | Eingeleitet | Raymond James | Outperform |
| 2021-10-20 | Fortgesetzt | Cowen | Outperform |
| 2021-03-02 | Eingeleitet | Stifel | Buy |
| 2021-02-18 | Eingeleitet | Needham | Buy |
| 2020-12-16 | Eingeleitet | UBS | Buy |
| 2020-12-08 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2020-07-02 | Eingeleitet | JP Morgan | Overweight |
| 2020-06-25 | Fortgesetzt | BofA/Merrill | Buy |
| 2020-06-01 | Fortgesetzt | Oppenheimer | Outperform |
| 2019-11-06 | Eingeleitet | Chardan Capital Markets | Buy |
| 2019-09-26 | Eingeleitet | Piper Jaffray | Overweight |
| 2019-04-23 | Eingeleitet | Robert W. Baird | Outperform |
| 2019-03-15 | Eingeleitet | BofA/Merrill | Buy |
| 2019-02-05 | Eingeleitet | Oppenheimer | Outperform |
| 2018-09-13 | Eingeleitet | Ladenburg Thalmann | Buy |
| 2018-07-10 | Eingeleitet | William Blair | Outperform |
Alle ansehen
Rocket Pharmaceuticals Inc Aktie (RCKT) Neueste Nachrichten
Published on: 2025-11-04 06:06:07 - newser.com
How to use Fibonacci retracement on Rocket Pharmaceuticals Inc.Dollar Strength & Real-Time Market Trend Scan - newser.com
How Rocket Pharmaceuticals Inc. (9IP1) stock trades pre earnings2025 Retail Activity & Precise Swing Trade Entry Alerts - newser.com
What dividend safety score for Rocket Pharmaceuticals Inc. stockJuly 2025 Drop Watch & Long-Term Safe Return Strategies - newser.com
Detecting support and resistance levels for Rocket Pharmaceuticals Inc.Market Sentiment Summary & Risk Adjusted Buy/Sell Alerts - newser.com
Using data models to predict Rocket Pharmaceuticals Inc. Equity Warrant stock movement2025 Big Picture & Technical Confirmation Alerts - newser.com
Can Rocket Pharmaceuticals Inc. stock withstand economic slowdownJuly 2025 Reactions & Safe Capital Growth Tips - newser.com
How Rocket Pharmaceuticals Inc. Equity Warrant stock benefits from tech adoption2025 Stock Rankings & Community Consensus Stock Picks - newser.com
Is Rocket Pharmaceuticals Inc. (9IP1) stock undervalued after correction2025 Investor Takeaways & Long-Term Safe Investment Plans - newser.com
How to integrate Rocket Pharmaceuticals Inc. Equity Warrant into portfolio analysis tools - newser.com
Risk adjusted return profile for Rocket Pharmaceuticals Inc. analyzedPortfolio Return Report & High Accuracy Swing Entry Alerts - newser.com
Using R and stats models for Rocket Pharmaceuticals Inc. forecastingQuarterly Earnings Report & Weekly Consistent Profit Watchlists - newser.com
Rocket Pharmaceuticals Inc. stock chart pattern explainedJuly 2025 Intraday Action & Community Consensus Stock Picks - newser.com
How Rocket Pharmaceuticals Inc. Equity Warrant stock reacts to inflationary pressuresJuly 2025 Action & Target Return Focused Picks - newser.com
What’s next for Rocket Pharmaceuticals Inc. stock priceMarket Activity Summary & Consistent Profit Focused Trading Strategies - newser.com
Is Rocket Pharmaceuticals Inc. Equity Warrant stock poised for growth2025 Growth vs Value & AI Powered Market Entry Strategies - newser.com
Published on: 2025-11-03 08:59:54 - newser.com
Is Rocket Pharmaceuticals Inc. Equity Warrant stock a safe haven asset2025 Momentum Check & Expert Curated Trade Ideas - newser.com
Is Rocket Pharmaceuticals Inc. stock entering bullish territoryJuly 2025 Short Interest & Smart Money Movement Alerts - newser.com
Can Rocket Pharmaceuticals Inc. stock deliver strong Q4 earningsMarket Activity Recap & Verified Swing Trading Watchlists - newser.com
Is it time to cut losses on Rocket Pharmaceuticals Inc. Equity WarrantMarket Growth Summary & Weekly Breakout Watchlists - newser.com
How Rocket Pharmaceuticals Inc. Equity Warrant stock compares to industry benchmarksChart Signals & Weekly Top Stock Performers List - newser.com
Long term hold vs stop loss in Rocket Pharmaceuticals Inc.2025 Support & Resistance & Short-Term High Return Ideas - newser.com
Will Rocket Pharmaceuticals Inc. Equity Warrant see short term momentumMarket Activity Report & Real-Time Chart Breakout Alerts - newser.com
Published on: 2025-11-03 04:17:02 - newser.com
Will Rocket Pharmaceuticals Inc. Equity Warrant stock benefit from upcoming earnings reports2025 Momentum Check & Weekly Return Optimization Alerts - newser.com
Will Rocket Pharmaceuticals Inc. (9IP1) stock see insider accumulationJuly 2025 Decliners & Short-Term Trading Opportunity Alerts - newser.com
Is Rocket Pharmaceuticals Inc. (9IP1) stock good for wealth creationMarket Trend Report & Safe Capital Growth Tips - newser.com
Applying big data sentiment scoring on Rocket Pharmaceuticals Inc. Equity Warrant2025 Volatility Report & Free Weekly Watchlist of Top Performers - newser.com
Published on: 2025-11-03 01:22:42 - newser.com
Sentiment analysis tools applied to Rocket Pharmaceuticals Inc.Trade Exit Report & Free AI Powered Buy and Sell Recommendations - newser.com
Why Rocket Pharmaceuticals Inc. stock is in analyst buy zoneSell Signal & Free Weekly Chart Analysis and Trade Guides - newser.com
Rocket Pharmaceuticals Inc. Equity Warrant recovery potential after sell offQuarterly Portfolio Review & Fast Gaining Stock Reports - newser.com
Rocket Pharmaceuticals Announces Dr. Patel’s Departure Agreement - MSN
What technical models suggest about Rocket Pharmaceuticals Inc.’s comeback2025 Fundamental Recap & Weekly Momentum Stock Picks - newser.com
Applying big data sentiment scoring on Rocket Pharmaceuticals Inc.2025 Macro Impact & Technical Confirmation Alerts - newser.com
Will a bounce in Rocket Pharmaceuticals Inc. offer an exitWeekly Gains Summary & Fast Exit and Entry Trade Guides - newser.com
Finanzdaten der Rocket Pharmaceuticals Inc-Aktie (RCKT)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.45%
0.86%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):